- Report
- August 2022
- 113 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- August 2024
- 200 Pages
Global
From €4373EUR$4,949USD£3,788GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2465EUR$2,789USD£2,135GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2465EUR$2,789USD£2,135GBP
- Report
- June 2025
- 250 Pages
India
From €2465EUR$2,789USD£2,135GBP
- Report
- June 2025
- 250 Pages
Japan
From €2465EUR$2,789USD£2,135GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2465EUR$2,789USD£2,135GBP
- Report
- March 2024
- 108 Pages
North America
From €3049EUR$3,450USD£2,640GBP
- Report
- January 2024
- 125 Pages
North America
From €3049EUR$3,450USD£2,640GBP
- Report
- January 2024
- 102 Pages
From €3049EUR$3,450USD£2,640GBP
- Report
- January 2024
- 134 Pages
Europe
From €3049EUR$3,450USD£2,640GBP
- Report
- January 2024
- 120 Pages
Africa, Middle East
From €3049EUR$3,450USD£2,640GBP
- Report
- January 2024
- 167 Pages
Asia Pacific
From €3049EUR$3,450USD£2,640GBP
- Report
- November 2022
- 208 Pages
Asia Pacific
From €3049EUR$3,450USD£2,640GBP
- Report
- July 2024
- 148 Pages
Asia Pacific
From €3049EUR$3,450USD£2,640GBP
- Report
- September 2023
- 272 Pages
Global
From €3932EUR$4,450USD£3,406GBP
- Report
- October 2025
- 70 Pages
Saudi Arabia
From €2253EUR$2,550USD£1,952GBP
- Report
- April 2024
- 407 Pages
Global
From €3181EUR$3,600USD£2,755GBP
- Report
- April 2024
- 170 Pages
Middle East, Africa
From €1326EUR$1,500USD£1,148GBP
- Report
- April 2024
- 172 Pages
Asia Pacific
From €1326EUR$1,500USD£1,148GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more